Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in J Med Virol

Retrieve available abstracts of 62 articles:
HTML format
Text format



Single Articles


    April 2017
  1. JABLONOWSKA E, Pulik P, Kalinowska A, Gasiorowski J, et al
    "Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients".
    J Med Virol. 2017 Apr 8. doi: 10.1002/jmv.24826.
    PubMed     Text format     Abstract available


  2. DUBE MANDISHORA RS, Christiansen IK, Chin'ombe N, Duri K, et al
    Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
    J Med Virol. 2017 Apr 8. doi: 10.1002/jmv.24825.
    PubMed     Text format     Abstract available


    March 2017
  3. HUSAIN M, Sharma U, Gupta P, Singhal M, et al
    Comparative genetic variability in HIV-1 subtype C nef gene in early age groups of infants.
    J Med Virol. 2017 Mar 31. doi: 10.1002/jmv.24820.
    PubMed     Text format     Abstract available


  4. SNELL LB, Smith C, Chaytor S, McRae K, et al
    Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis.
    J Med Virol. 2017 Mar 31. doi: 10.1002/jmv.24818.
    PubMed     Text format     Abstract available


  5. COMAR M, Seraceni S, Colli C, Luska V, et al
    Chlamydia trachomatis and HPV co-infections in HIV negative men from a multi-ethnic area of Northern Italy at high prevalence of cervical malignancies.
    J Med Virol. 2017 Mar 18. doi: 10.1002/jmv.24811.
    PubMed     Text format     Abstract available


  6. LIU Z, Fang Q, Zhou S, Minhas V, et al
    Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.
    J Med Virol. 2017 Mar 2. doi: 10.1002/jmv.24804.
    PubMed     Text format     Abstract available


    February 2017
  7. AUGUSTO A, Augusto O, Taquimo A, Nhachigule C, et al
    First description of HTLV-1/2 seroprevalence in HIV-infected inmates in Mozambique.
    J Med Virol. 2017 Feb 27. doi: 10.1002/jmv.24801.
    PubMed     Text format     Abstract available


  8. SAMLEERAT T, Hongjaisee S, Phiayura P, Sirirungsi W, et al
    HIV-1 coreceptor usage in perinatally infected Thai children.
    J Med Virol. 2017 Feb 15. doi: 10.1002/jmv.24790.
    PubMed     Text format     Abstract available


  9. ZHANG L, Wang B, Liang Y, Feng Y, et al
    Phylogenetic characteristics of HIV-1 among travelers entering China from Myanmar: A retrospective study.
    J Med Virol. 2017 Feb 15. doi: 10.1002/jmv.24786.
    PubMed     Text format     Abstract available


  10. FLORES GL, Cruz HM, Marques VA, Villela-Nogueira CA, et al
    Performance of anti-HCV testing in dried blood spots and saliva according to HIV status.
    J Med Virol. 2017 Feb 6. doi: 10.1002/jmv.24777.
    PubMed     Text format     Abstract available


    January 2017
  11. GRANDAL M, Pernas B, Marino A, Alvarez H, et al
    Characterization of chronic HCV infection in Northwest Spain: Impact of the treatment strategic plan of the Spanish National Health Service on HCV cure.
    J Med Virol. 2017 Jan 12. doi: 10.1002/jmv.24766.
    PubMed     Text format     Abstract available


    December 2016
  12. PAIVA A, Smid J, Haziot ME, Assone T, et al
    High risk of heterosexual transmission of human T-cell lymphotropic virus type 1 infection in Brazil.
    J Med Virol. 2016 Dec 9. doi: 10.1002/jmv.24745.
    PubMed     Text format     Abstract available


  13. KODANI M, Ahmed N, Tejada-Strop A, Poe A, et al
    Variability in the performance characteristics of IgG anti-HEV assays and its impact on reliability of seroprevalence rates of hepatitis E.
    J Med Virol. 2016 Dec 6. doi: 10.1002/jmv.24741.
    PubMed     Text format     Abstract available


  14. WANG B, Liang Y, Wang Y, Feng Y, et al
    HIV prevalence and phylogenetic characteristics among entry travelers in Xishuangbanna prefecture, Yunnan Province, between 2003 and 2012.
    J Med Virol. 2016 Dec 6. doi: 10.1002/jmv.24740.
    PubMed     Text format     Abstract available


    November 2016
  15. SHARMA AL, Singh TR, Devi KR, Singh LS, et al
    Molecular epidemiology of HIV-1 among the HIV infected people of Manipur, Northeastern India: Emergence of unique recombinant forms.
    J Med Virol. 2016 Nov 21. doi: 10.1002/jmv.24738.
    PubMed     Text format     Abstract available


  16. SALEMI JL, Spooner KK, Mejia de Grubb MC, Aggarwal A, et al
    National trends of hepatitis B and C during pregnancy across sociodemographic, behavioral, and clinical factors, United States, 1998-2011.
    J Med Virol. 2016 Nov 2. doi: 10.1002/jmv.24725.
    PubMed     Text format     Abstract available


    October 2016
  17. WANG N, Li Y, Han Y, Xie J, et al
    HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy.
    J Med Virol. 2016 Oct 28. doi: 10.1002/jmv.24723.
    PubMed     Text format     Abstract available


  18. LIU Z, Fang Q, Zuo J, Wang J, et al
    High seroprevalence of human herpesvirus 8 and herpes simplex virus 2 infections in men who have sex with men in Shanghai, China.
    J Med Virol. 2016 Oct 21. doi: 10.1002/jmv.24718.
    PubMed     Text format     Abstract available


    September 2016
  19. JOGEDA EL, Huik K, Pauskar M, Kallas E, et al
    The prevalence and genotypes of GBV-C and its associations with HIV infection among persons who inject drugs in Eastern Europe.
    J Med Virol. 2016 Sep 7. doi: 10.1002/jmv.24683.
    PubMed     Text format     Abstract available


  20. SLAVOV SN, Otaguiri KK, Smid J, de Oliveira AC, et al
    Human parvovirus 4 prevalence among HTLV-1/2 infected individuals in Brazil.
    J Med Virol. 2016 Sep 2. doi: 10.1002/jmv.24673.
    PubMed     Text format     Abstract available


    August 2016
  21. WU S, Yan P, Yang T, Wang Z, et al
    Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China.
    J Med Virol. 2016 Aug 23. doi: 10.1002/jmv.24666.
    PubMed     Text format     Abstract available


    July 2016
  22. DE PASCHALE M, Manco MT, Belvisi L, Cagnin D, et al
    Evaluation of LIAISON(R) XL system for HBsAg, and anti-HCV and anti-HIV/Ag p24.
    J Med Virol. 2016 Jul 28. doi: 10.1002/jmv.24648.
    PubMed     Text format     Abstract available


  23. VARMAZYAR S, Shoja Z, Kakavand-Ghalehnoei R, Shahmahmoodi S, et al
    Molecular typing of human herpesvirus 8 among HIV positive in comparison to HIV-negative individuals in Iran.
    J Med Virol. 2016 Jul 27. doi: 10.1002/jmv.24644.
    PubMed     Text format     Abstract available


  24. BAUDI I, Iijima S, Chin'ombe N, Mtapuri-Zinyowera S, et al
    Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe.
    J Med Virol. 2016 Jul 26. doi: 10.1002/jmv.24641.
    PubMed     Text format     Abstract available


  25. OLESEN TB, Mwaiselage J, Iftner T, Kahesa C, et al
    Risk factors for genital Human Papillomavirus among men in Tanzania.
    J Med Virol. 2016 Jul 12. doi: 10.1002/jmv.24627.
    PubMed     Text format     Abstract available


  26. SADEGHI A, Shirvani-Dastgerdi E, Tacke F, Yagmur E, et al
    HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg.
    J Med Virol. 2016 Jul 6. doi: 10.1002/jmv.24623.
    PubMed     Text format     Abstract available


  27. OLIVEIRA MP, Lemes PS, Matos MA, Del-Rios NH, et al
    Overt and occult hepatitis B virus infection among treatment-naive HIV-infected patients in Brazil.
    J Med Virol. 2016;88:1222-9.
    PubMed     Text format     Abstract available


    June 2016
  28. KAMORI D, Hasan Z, Ohashi J, Kawana-Tachikawa A, et al
    Identification of two unique naturally occurring Vpr sequence polymorphisms associated with clinical parameters in HIV-1 chronic infection.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24612.
    PubMed     Text format     Abstract available


  29. DIMONTE S
    Different HIV-1 env frames: gp120 and ASP (antisense protein) biosynthesis, and theirs co-variation tropic amino acid signatures in X4- and R5-viruses.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24611.
    PubMed     Text format     Abstract available


  30. ARALAGUPPE SG, Winner D, Singh K, Sarafianos SG, et al
    Increased replication capacity following evolution of PYxE insertion in gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24610.
    PubMed     Text format     Abstract available


  31. BEGHIN JC, Ruelle J, Sokal E, Bachy A, et al
    Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus-1 living in a resource-limited setting of Kwazulu-Natal.
    J Med Virol. 2016 Jun 13. doi: 10.1002/jmv.24598.
    PubMed     Text format     Abstract available


    May 2016
  32. ROSCA A, Anton G, Botezatu A, Temereanca A, et al
    miR-29a associates with viro-immunological markers of HIV infection in treatment experienced patients.
    J Med Virol. 2016 May 27. doi: 10.1002/jmv.24586.
    PubMed     Text format     Abstract available


  33. PERNAS B, Grandal M, Tabernilla A, Cid P, et al
    Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain.
    J Med Virol. 2016 May 24. doi: 10.1002/jmv.24585.
    PubMed     Text format     Abstract available


  34. MICHELINI Z, Galluzzo CM, Pirillo MF, Francisci D, et al
    HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy.
    J Med Virol. 2016 May 19. doi: 10.1002/jmv.24581.
    PubMed     Text format     Abstract available


  35. MOTA LD, Nishiya AS, Finger-Jardim F, Barral MF, et al
    Prevalence of human pegivirus (HPgV) infection in patients carrying HIV-1C or non-C in southern Brazil.
    J Med Virol. 2016 May 12. doi: 10.1002/jmv.24574.
    PubMed     Text format     Abstract available


  36. ALBERTI A, Lacoin L, Morais E, Lefevre C, et al
    A literature review of the distribution of hepatitis C virus genotypes across Europe.
    J Med Virol. 2016 May 12. doi: 10.1002/jmv.24573.
    PubMed     Text format     Abstract available


  37. ZHANG L, Tian Y, Wen Z, Zhang F, et al
    Asialoglycoprotein receptor facilitates infection of PLC/PRF/5 cells by HEV through interaction with ORF2.
    J Med Virol. 2016 May 7. doi: 10.1002/jmv.24570.
    PubMed     Text format     Abstract available


    April 2016
  38. KAHN JA, Rudy BJ, Xu J, Kapogiannis B, et al
    Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.
    J Med Virol. 2016 Apr 20. doi: 10.1002/jmv.24555.
    PubMed     Text format     Abstract available


  39. CAHU GG, Morais VM, Lopes TR, da Silva DM, et al
    Prevalence of Human herpesvirus 8 infection in people living with HIV/AIDS in Pernambuco, Brazil.
    J Med Virol. 2016 Apr 18. doi: 10.1002/jmv.24550.
    PubMed     Text format     Abstract available


  40. OLP LN, Minhas V, Gondwe C, Poppe LK, et al
    Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
    J Med Virol. 2016 Apr 7. doi: 10.1002/jmv.24546.
    PubMed     Text format     Abstract available


  41. NIE J, Liu J, Xie H, Sun Z, et al
    Multiple human papillomavirus infections and type-competition in woman from a clinic attendee population in China.
    J Med Virol. 2016 Apr 6. doi: 10.1002/jmv.24542.
    PubMed     Text format     Abstract available


  42. LIMA YA, Cardoso LP, Reis MN, Stefani MM, et al
    Incident and long term HIV-1 infection among pregnant women in Brazil: Transmitted drug resistance and mother-to-child transmission.
    J Med Virol. 2016 Apr 1. doi: 10.1002/jmv.24540.
    PubMed     Text format     Abstract available


  43. LI L, Sun G, Zhong P, Han J, et al
    HIV-1 Thai B strain has spread out of former plasma donors into general population through sexual contact in Henan, China.
    J Med Virol. 2016;88:614-21.
    PubMed     Text format     Abstract available


    March 2016
  44. COPPOLA N, Minichini C, Starace M, Sagnelli C, et al
    Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals.
    J Med Virol. 2016 Mar 18. doi: 10.1002/jmv.24527.
    PubMed     Text format     Abstract available


  45. CHIN BS, Chaillon A, Mehta SR, Wertheim JO, et al
    Molecular epidemiology identifies HIV transmission networks associated with younger age and heterosexual exposure among Korean individuals.
    J Med Virol. 2016 Mar 17. doi: 10.1002/jmv.24523.
    PubMed     Text format     Abstract available


    February 2016
  46. AL-MUGHALES JA
    Co-infection assessment in HBV, HCV and HIV patients in western Saudi Arabia.
    J Med Virol. 2016 Feb 19. doi: 10.1002/jmv.24503.
    PubMed     Text format     Abstract available


  47. GEDEDZHA MP, Muzeze M, Burnett RJ, Amponsah-Dacosta E, et al
    Complete genome analysis of hepatitis B virus in human immunodeficiency virus infected and uninfected South Africans.
    J Med Virol. 2016 Feb 17. doi: 10.1002/jmv.24502.
    PubMed     Text format     Abstract available


  48. AMENDOLA A, Pisciotta M, Aleo L, Ferraioli V, et al
    Evaluation of the Aptima(R) HIV-1 Quant Dx assay for HIV-1 RNA viral load detection and quantitation in plasma of HIV-1 infected individuals: A comparison with Abbott RealTime HIV-1 assay.
    J Med Virol. 2016 Feb 10. doi: 10.1002/jmv.24493.
    PubMed     Text format     Abstract available


  49. LIU MQ, Zhu ZR, Kong WH, Tang L, et al
    High rate of missed HIV infections in individuals with indeterminate or negative HIV western blots based on current HIV testing algorithm in China.
    J Med Virol. 2016 Feb 9. doi: 10.1002/jmv.24490.
    PubMed     Text format     Abstract available


    January 2016
  50. ASIYABI S, Nejati A, Shoja Z, Shahmahmoodi S, et al
    First report of human parvovirus 4 detection in Iran.
    J Med Virol. 2016 Jan 27. doi: 10.1002/jmv.24485.
    PubMed     Text format     Abstract available


  51. D'ETTORRE G, Ceccarelli G, Serafino S, Giustini N, et al
    Dominant enrichment of phenotypically activated CD38 HLA-DR CD8 T cells, rather than CD38 HLA-DR CD4 T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    J Med Virol. 2016 Jan 14. doi: 10.1002/jmv.24475.
    PubMed     Text format     Abstract available


  52. BOKHARAEI-SALIM F, Keyvani H, Esghaei M, Zare-Karizi S, et al
    Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.
    J Med Virol. 2016 Jan 14. doi: 10.1002/jmv.24474.
    PubMed     Text format     Abstract available


    December 2015
  53. ZHANG L, Cai C, Pan F, Hong L, et al
    An epidemiologic study of human parvovirus B19 infection in East China.
    J Med Virol. 2015 Dec 24. doi: 10.1002/jmv.24459.
    PubMed     Text format     Abstract available


  54. LO G, Sow-Sall A, Diop-Ndiaye H, Mandiouba NC, et al
    Response to comments by Honge et al. on our paper titled "Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients".
    J Med Virol. 2015 Dec 22. doi: 10.1002/jmv.24452.
    PubMed     Text format     Abstract available


  55. HONGE BL, Jespersen S, Medina C, Wejse C, et al
    Comment on Lo et al.: Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients.
    J Med Virol. 2015 Dec 22. doi: 10.1002/jmv.24455.
    PubMed     Text format     Abstract available


  56. DELORY T, Papot E, Rioux C, Charpentier C, et al
    Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
    J Med Virol. 2015 Dec 4. doi: 10.1002/jmv.24442.
    PubMed     Text format     Abstract available


  57. SCAGGIANTE R, Andreis S, Basso M, Franchin E, et al
    Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.
    J Med Virol. 2015 Dec 4. doi: 10.1002/jmv.24441.
    PubMed     Text format     Abstract available


    November 2015
  58. DE ARAUJO MARIZ C, Lopes EP, Ximenes RA, Lacerda HR, et al
    Serological markers of hepatitis B and C in patients with HIV/AIDS and active tuberculosis.
    J Med Virol. 2015 Nov 18. doi: 10.1002/jmv.24432.
    PubMed     Text format     Abstract available


  59. SHAH K, Ragupathy V, Saga A, Hewlett I, et al
    High sensitivity detection of HIV-1 using two genomic targets compared with single target PCR.
    J Med Virol. 2015 Nov 17. doi: 10.1002/jmv.24431.
    PubMed     Text format     Abstract available


    October 2015
  60. ZHU JW, Liu FL, Mu D, Deng DY, et al
    Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients.
    J Med Virol. 2015 Oct 31. doi: 10.1002/jmv.24419.
    PubMed     Text format     Abstract available


  61. FREZZA C, Grelli S, Federico M, Marino-Merlo F, et al
    Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3.
    J Med Virol. 2015 Oct 31. doi: 10.1002/jmv.24418.
    PubMed     Text format     Abstract available


  62. GANTT S, Leister E, Jacobson DL, Boucoiran I, et al
    Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.
    J Med Virol. 2015 Oct 31. doi: 10.1002/jmv.24420.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: